Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Surging Free Cash Flow Makes Walmart a Star

By Mark R. Hake, CFA

Walmart's surging free cash flow makes the stock very attractive. Walmart stock has a higher FCF yield than Amazon so the stock should be much higher despite its lower margins.

With Higher-than-Walmart FCF Margins, Target Stock Merits Richer Valuation

By Mark R. Hake, CFA

With higher FCF margins than Walmart, Target stock is worth at least 50% more, despite its lower P/E and FCF yield.

GoDaddy Stock Is Very Cheap and Deserves a Look

By Mark R. Hake, CFA

GoDaddy stock is very cheap compared to its peers. I think GDDY is worth triple its present price based on several metrics.

Novavax Looks Like a Winner With Its Vaccine Results

By Mark R. Hake, CFA

Novavax looks like a winner with its positive Covid-19 vaccine results. NVAX stock is worth at least 35% more than today based on widespread acceptance of its vaccine.

Beyond Meat’s Outlook Remains Murky At Best

By Mark R. Hake, CFA

Beyond Meat's stock is likely to fall, given its average margins and decelerating growth. Consider taking profits in BYND stock now.

Load More